Last reviewed · How we verify

Ultrasound guided erector spinae plane block

Maltepe University · Phase 1 active Small molecule Quality 3/100

Ultrasound guided erector spinae plane block is a Small molecule drug developed by Maltepe University. It is currently in Phase 1 development.

At a glance

Generic nameUltrasound guided erector spinae plane block
SponsorMaltepe University
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Ultrasound guided erector spinae plane block

What is Ultrasound guided erector spinae plane block?

Ultrasound guided erector spinae plane block is a Small molecule drug developed by Maltepe University.

Who makes Ultrasound guided erector spinae plane block?

Ultrasound guided erector spinae plane block is developed by Maltepe University (see full Maltepe University pipeline at /company/maltepe-university).

What development phase is Ultrasound guided erector spinae plane block in?

Ultrasound guided erector spinae plane block is in Phase 1.

What are the side effects of Ultrasound guided erector spinae plane block?

Common side effects of Ultrasound guided erector spinae plane block include Ileus, Respiratory Depression.

Related